DrugBiological
Florilglutamic acid f-18 clinical trials
Also written BAY94-9392 and 18F-FSPG.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Development codes
Other names
Studies by the year they started
10 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 5
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 7
Life Molecular Imaging SA (3) · M.D. Anderson Cancer Center (2) · Andrei Iagaru (2) · Vanderbilt-Ingram Cancer Center (2) · Stanford University (1)
Often tested with
Tested in the same studies.
Fluorodeoxyglucose F18 (1) · Glutamine 5-C-11 (1)
Studies
Open first, then newest update. How each study uses florilglutamic acid f-18 is read from its arms, and is right about nine times in ten.
Testing it · 10
- 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or TransplantActive, not recruitingPhase 1M.D. Anderson Cancer CenterNCT02379377Written as Fluorine F 18 L-glutamate Derivative 18F-FSPG
- Glutamine PET Imaging Colorectal CancerTerminatedPhase 1M.D. Anderson Cancer CenterNCT03275974Written as Fluorine F 18 L-glutamate Derivative BAY94-9392
- 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung NodulesCompletedPhase 2Andrei IagaruNCT03824535Written as Fluorine F 18 L-glutamate Derivative BAY94-9392
- 18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or InflammationTerminatedPhase 2Stanford UniversityNCT03103490Written as 18F-FSPG
- 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary NodulesCompletedPhase 2Vanderbilt-Ingram Cancer CenterNCT02448225Written as Fluorine F 18 L-glutamate Derivative BAY94-9392
- 18F-FSPG PET/CT for Cancer Patients on TherapyCompletedPhase 2Andrei IagaruNCT02599194Written as 18F-FSPG
- PET Imaging of Ovarian Carcinoma With 18F-FSPGWithdrawnEarly Phase 1Vanderbilt-Ingram Cancer CenterNCT02872519Written as (S)-4-(3-[18F]Fluoropropyl)-L-glutamic acid (18F-FSPG)
- PET Imaging of Intracranial Cancers With 18F-FSPGTerminatedPhase 1Life Molecular Imaging SANCT02370563Written as 18F-FSPG
- Exploration of Tumor Accumulation of BAY94-9392 in Patients With CancerCompletedPhase 1Life Molecular Imaging SANCT01186601Written as PET tracer (BAY94-9392)
- Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or InflammationCompletedPhase 1Life Molecular Imaging SANCT01103310Written as BAY94-9392
Codes
What other systems call florilglutamic acid f-18 · ClinicalTrials.gg INT015765
- UNII (FDA) 92T1Y5X038FLORILGLUTAMIC ACID F-18Confirmed FDA, Wikidata
- Wikidata Q27271529florilglutamic acid f-18Confirmed FDA, Wikidata
- DrugBank DB15041One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 92T1Y5X038 | FLORILGLUTAMIC ACID F-18 | Confirmed FDA, Wikidata |
| Wikidata | Q27271529 | florilglutamic acid f-18 | Confirmed FDA, Wikidata |
| DrugBank | DB15041 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.